Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism

Neuropharmacology

Volumn 68, Issue , 2013, Pages 210-222

  Silverman, Jill L ^a,b   Babineau, Brooke A ^a   Oliver, Chicora F ^a   Karras, Michael N ^a   Crawley, Jacqueline N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; BTBR; Mouse model; Neurodevelopmental disorder; Repetitive behavior; Social behavior

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BTBR MOUSE; C57BL 6 MOUSE; COMPULSION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MEGADOSE; EXPLORATORY BEHAVIOR; FEMALE; GROOMING; HYPERACTIVITY; INBRED STRAIN; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OPEN FIELD BEHAVIOR; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; SNIFFING TIME; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ANIMALS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; DEXTROAMPHETAMINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GROOMING; HYPERKINESIS; MICE; MICE, INBRED C57BL; SOCIAL BEHAVIOR;

EID: 84875218222     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.07.042     Document Type: Article

References (110)

1. B.S. Abrahams, and D.H. Geschwind Advances in autism genetics: on the threshold of a new neurobiology Nat. Rev. Genet. 9 2008 341 355
2. B.S. Abrahams, and D.H. Geschwind Connecting genes to brain in the autism spectrum disorders Arch. Neurol. 67 2010 395 399
3. American Psychiatric Association Diagnostic Criteria from DSM-IV 1994 The Association Washington, D.C.
4. R. Anney, L. Klei, D. Pinto, R. Regan, J. Conroy, T.R. Magalhaes, C. Correia, B.S. Abrahams, N. Sykes, A.T. Pagnamenta, J. Almeida, E. Bacchelli, A.J. Bailey, G. Baird, A. Battaglia, T. Berney, N. Bolshakova, S. Bolte, P.F. Bolton, T. Bourgeron, S. Brennan, J. Brian, A.R. Carson, G. Casallo, J. Casey, S.H. Chu, L. Cochrane, C. Corsello, E.L. Crawford, A. Crossett, G. Dawson, M. de Jonge, R. Delorme, I. Drmic, E. Duketis, F. Duque, A. Estes, P. Farrar, B.A. Fernandez, S.E. Folstein, E. Fombonne, C.M. Freitag, J. Gilbert, C. Gillberg, J.T. Glessner, J. Goldberg, J. Green, S.J. Guter, H. Hakonarson, E.A. Heron, M. Hill, R. Holt, J.L. Howe, G. Hughes, V. Hus, R. Igliozzi, C. Kim, S.M. Klauck, A. Kolevzon, O. Korvatska, V. Kustanovich, C.M. Lajonchere, J.A. Lamb, M. Laskawiec, M. Leboyer, A. Le Couteur, B.L. Leventhal, A.C. Lionel, X.Q. Liu, C. Lord, L. Lotspeich, S.C. Lund, E. Maestrini, W. Mahoney, C. Mantoulan, C.R. Marshall, H. McConachie, C.J. McDougle, J. McGrath, W.M. McMahon, N.M. Melhem, A. Merikangas, O. Migita, N.J. Minshew, G.K. Mirza, J. Munson, S.F. Nelson, C. Noakes, A. Noor, G. Nygren, G. Oliveira, K. Papanikolaou, J.R. Parr, B. Parrini, T. Paton, A. Pickles, J. Piven, D.J. Posey, A. Poustka, F. Poustka, A. Prasad, J. Ragoussis, K. Renshaw, J. Rickaby, W. Roberts, K. Roeder, B. Roge, M.L. Rutter, L.J. Bierut, J.P. Rice, J. Salt, K. Sansom, D. Sato, R. Segurado, L. Senman, N. Shah, V.C. Sheffield, L. Soorya, I. Sousa, V. Stoppioni, C. Strawbridge, R. Tancredi, K. Tansey, B. Thiruvahindrapduram, A.P. Thompson, S. Thomson, A. Tryfon, J. Tsiantis, H. Van Engeland, J.B. Vincent, F. Volkmar, S. Wallace, K. Wang, Z. Wang, T.H. Wassink, K. Wing, K. Wittemeyer, S. Wood, B.L. Yaspan, D. Zurawiecki, L. Zwaigenbaum, C. Betancur, J.D. Buxbaum, R.M. Cantor, E.H. Cook, H. Coon, M.L. Cuccaro, L. Gallagher, D.H. Geschwind, M. Gill, J.L. Haines, J. Miller, A.P. Monaco, J.I. Nurnberger Jr.; A.D. Paterson, M.A. Pericak-Vance, G.D. Schellenberg, S.W. Scherer, J.S. Sutcliffe, P. Szatmari, A.M. Vicente, V.J. Vieland, E.M. Wijsman, B. Devlin, S. Ennis, and J. Hallmayer A genome-wide scan for common alleles affecting risk for autism Hum. Mol. Genet. 19 2010 4072 4082
5. K. Antoniou, E. Kafetzopoulos, Z. Papadopoulou-Daifoti, T. Hyphantis, and M. Marselos D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats Neurosci. Biobehav. Rev. 23 1998 189 196
6. K.R. Bailey, M.N. Pavlova, A.D. Rohde, J.G. Hohmann, and J.N. Crawley Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze Pharmacol. Biochem. Behav. 86 2007 8 20
7. M.F. Bear, K.M. Huber, and S.T. Warren The mGluR theory of fragile X mental retardation Trends Neurosci. 27 2004 370 377
8. M.F. Bear, G. Dolen, E. Osterweil, and N. Nagarajan Fragile X: translation in action Neuropsychopharmacology 33 2008 84 87
9. R. Benno, Y. Smirnova, S. Vera, A. Liggett, and N. Schanz Exaggerated responses to stress in the BTBR T+tf/J mouse: an unusual behavioral phenotype Behav. Brain Res. 197 2009 462 465
10. V.J. Bolivar, S.R. Walters, and J.L. Phoenix Assessing autism-like behavior in mice: variations in social interactions among inbred strains Behav. Brain Res. 176 2007 21 26
11. V. Bolivar, M. Solanki, W. Du, S. Day, and K. Manley Autism-like Behaviors in Mice Are Modified by Genetic Background, Sex and Testing Protocol 2011 Society for Neuroscience Washington D.C.
12. G. Bothe, M. Solanki, W. Du, G. Kusek, R. Auerbach, K. Manley, and V. Bolivar Genetic Investigations of Corpus Callosum Abnormalities in BTBR T+tf/j Mice 2011 Society for Neuroscience Washington DC
13. J. Brielmaier, P.G. Matteson, J.L. Silverman, J.M. Senerth, S. Kelly, M. Genestine, J.H. Millonig, E. DiCicco-Bloom, and J.N. Crawley Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice PLoS One 2012
14. E.S. Brodkin, A. Hagemann, S.M. Nemetski, and L.M. Silver Social approach-avoidance behavior of inbred mouse strains towards DBA/2 mice Brain Res. 1002 2004 151 157
15. E.S. Brodkin BALB/c mice: low sociability and other phenotypes that may be relevant to autism Behav. Brain Res. 176 2007 53 65
16. M. Bucan, B.S. Abrahams, K. Wang, J.T. Glessner, E.I. Herman, L.I. Sonnenblick, A.I. Alvarez Retuerto, M. Imielinski, D. Hadley, J.P. Bradfield, C. Kim, N.B. Gidaya, I. Lindquist, T. Hutman, M. Sigman, V. Kustanovich, C.M. Lajonchere, A. Singleton, J. Kim, T.H. Wassink, W.M. McMahon, T. Owley, J.A. Sweeney, H. Coon, J.I. Nurnberger, M. Li, R.M. Cantor, N.J. Minshew, J.S. Sutcliffe, E.H. Cook, G. Dawson, J.D. Buxbaum, S.F. Grant, G.D. Schellenberg, D.H. Geschwind, and H. Hakonarson Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes PLoS Genet. 5 2009 e1000536
17. M. Cador, J. Dulluc, and P. Mormede Modulation of the locomotor response to amphetamine by corticosterone Neuroscience 56 1993 981 988
18. K.K. Chadman, S. Gong, M.L. Scattoni, S.E. Boltuck, S.U. Gandhy, N. Heintz, and J.N. Crawley Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice Autism Res. 1 2008 147 158
19. S. Cobb, J. Guy, and A. Bird Reversibility of functional deficits in experimental models of Rett syndrome Biochem. Soc. Trans. 38 2010 498 506
20. A.R. Cools Differential role of mineralocorticoid and glucocorticoid receptors in the genesis of dexamphetamine-induced sensitization of mesolimbic, alpha 1 adrenergic receptors in the ventral striatum Neuroscience 43 1991 419 428
21. G. Dawson, S. Rogers, J. Munson, M. Smith, J. Winter, J. Greenson, A. Donaldson, and J. Varley Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model Pediatrics 125 2010 e17 23
22. G. Dawson Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder Dev. Psychopathol. 20 2008 775 803
23. F.M. de Vrij, J. Levenga, H.C. van der Linde, S.K. Koekkoek, C.I. De Zeeuw, D.L. Nelson, B.A. Oostra, and R. Willemsen Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice Neurobiol. Dis. 31 2008 127 132
24. E.B. Defensor, B.L. Pearson, R.L. Pobbe, V.J. Bolivar, D.C. Blanchard, and R.J. Blanchard A novel social proximity test suggests patterns of social avoidance and gaze aversion-like behavior in BTBR T+tf/J mice Behav. Brain Res. 217 2011 302 308
25. E. DiCicco-Bloom, C. Lord, L. Zwaigenbaum, E. Courchesne, S.R. Dager, C. Schmitz, R.T. Schultz, J. Crawley, and L.J. Young The developmental neurobiology of autism spectrum disorder J. Neurosci. 26 2006 6897 6906
26. G. Dolen, and M.F. Bear Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome J. Physiol. 586 2008 1503 1508
27. G. Dolen, E. Osterweil, B.S. Rao, G.B. Smith, B.D. Auerbach, S. Chattarji, and M.F. Bear Correction of fragile X syndrome in mice Neuron 56 2007 955 962
28. D. Ehninger, S. Han, C. Shilyansky, Y. Zhou, W. Li, D.J. Kwiatkowski, V. Ramesh, and A.J. Silva Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis Nat. Med. 14 2008 843 848
29. D. Ehninger, W. Li, K. Fox, M.P. Stryker, and A.J. Silva Reversing neurodevelopmental disorders in adults Neuron 60 2008 950 960
30. A.H. Fairless, R.Y. Shah, A.J. Guthrie, H. Li, and E.S. Brodkin Deconstructing sociability, an autism-relevant phenotype, in mouse models Anat. Rec. (Hoboken) 294 2011 1713 1725
31. F. Farzin, H. Perry, D. Hessl, D. Loesch, J. Cohen, S. Bacalman, L. Gane, F. Tassone, P. Hagerman, and R. Hagerman Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation J. Dev. Behav. Pediatr. 27 2006 S137 S144
32. C.A. Frye, and D.C. Llaneza Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice Physiol. Behav. 100 2010 264 267
33. J. Guy, J. Gan, J. Selfridge, S. Cobb, and A. Bird Reversal of neurological defects in a mouse model of Rett syndrome Science 315 2007 1143 1147
34. B.L. Handen, C.R. Johnson, and M. Lubetsky Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder J. Autism Dev. Disord. 30 2000 245 255
35. F. Happe, and A. Ronald The 'fractionable autism triad': a review of evidence from behavioural, genetic, cognitive and neural research Neuropsychol. Rev. 18 2008 287 304
36. M.L. Hayashi, B.S. Rao, J.S. Seo, H.S. Choi, B.M. Dolan, S.Y. Choi, S. Chattarji, and S. Tonegawa Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice Proc. Natl. Acad. Sci. U. S. A. 104 2007 11489 11494
37. Z.A. Hughes, S.J. Neal, D.L. Smith, S.J. Sukoff Rizzo, C.M. Pulicicchio, S. Lotarski, S. Lu, J.M. Dwyer, J. Brennan, M. Olsen, C.N. Bender, E. Kouranova, T.H. Andree, J.E. Harrison, G.T. Whiteside, D. Springer, S.V. O'Neill, S.K. Leonard, L.E. Schechter, J. Dunlop, S. Rosenzweig-Lipson, and R.H. Ring Negative allosteric modulation of metabolic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression Neuropharmacology Apr 21 2012 (Epub)
38. S. Jacquemont, A. Curie, V. des Portes, M.G. Torrioli, E. Berry-Kravis, R.J. Hagerman, F.J. Ramos, K. Cornish, Y. He, C. Paulding, G. Neri, F. Chen, N. Hadjikhani, D. Martinet, J. Meyer, J.S. Beckmann, K. Delange, A. Brun, G. Bussy, F. Gasparini, T. Hilse, A. Floesser, J. Branson, G. Bilbe, D. Johns, and B. Gomez-Mancilla Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056 Sci. Transl. Med. 3 64 Jan 5 2011 64ra1
39. L.B. Jahromi, C.L. Kasari, J.T. McCracken, L.S. Lee, M.G. Aman, C.J. McDougle, L. Scahill, E. Tierney, L.E. Arnold, B. Vitiello, L. Ritz, A. Witwer, E. Kustan, J. Ghuman, and D.J. Posey Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity J. Autism Dev. Disord. 39 2009 395 404
40. D. Jones-Davis, M. Yang, E. Rider, S. Sen, J. Crawley, and E. Sherr Identification of Loci Associated with Autism-relevant Behavioral Traits in the BTBR Strain of Mouse 2011 Society for Neuroscience Washington D.C.
41. P.W. Kalivas, and J. Stewart Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity Brain Res. Brain Res. Rev. 16 1991 223 244
42. A.E. Kelley, M. Winnock, and L. Stinus Amphetamine, apomorphine and investigatory behavior in the rat: analysis of the structure and pattern of responses Psychopharmacology (Berl) 88 1986 66 74
43. P. Kochhar, M.J. Batty, E.B. Liddle, M.J. Groom, G. Scerif, P.F. Liddle, and C.P. Hollis Autistic spectrum disorder traits in children with attention deficit hyperactivity disorder Child. Care Health Dev. 37 2011 103 110
44. L. Krasny, B.J. Williams, S. Provencal, and S. Ozonoff Social skills interventions for the autism spectrum: essential ingredients and a model curriculum Child. Adolesc. Psychiatr. Clin. N. Am. 12 2003 107 122
45. D.D. Krueger, and M.F. Bear Toward fulfilling the promise of molecular medicine in fragile X syndrome Annu. Rev. Med. 62 2011 411 429
46. R.J. Landa Diagnosis of autism spectrum disorders in the first 3 years of life Nat. Clin. Pract. Neurol. 4 2008 138 147
47. O.T. Leyfer, S.E. Folstein, S. Bacalman, N.O. Davis, E. Dinh, J. Morgan, H. Tager-Flusberg, and J.E. Lainhart Comorbid psychiatric disorders in children with autism: interview development and rates of disorders J. Autism Dev. Disord. 36 2006 849 861
48. C. Lord, S. Risi, L. Lambrecht, E.H. Cook Jr.; B.L. Leventhal, P.C. DiLavore, A. Pickles, and M. Rutter The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism J. Autism Dev. Disord. 30 2000 205 223
49. R.N. Marcus, R. Owen, G. Manos, R. Mankoski, L. Kamen, R.D. McQuade, W.H. Carson, P.K. Corey-Lisle, and M.G. Aman Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study J. Child. Adolesc. Psychopharmacol. 21 2011 229 236
50. J.T. McCracken, J. McGough, B. Shah, P. Cronin, D. Hong, M.G. Aman, L.E. Arnold, R. Lindsay, P. Nash, J. Hollway, C.J. McDougle, D. Posey, N. Swiezy, A. Kohn, L. Scahill, A. Martin, K. Koenig, F. Volkmar, D. Carroll, A. Lancor, E. Tierney, J. Ghuman, N.M. Gonzalez, M. Grados, B. Vitiello, L. Ritz, M. Davies, J. Robinson, and D. McMahon Risperidone in children with autism and serious behavioral problems N. Engl. J. Med. 347 2002 314 321
51. C.J. McDougle, L. Scahill, J.T. McCracken, M.G. Aman, E. Tierney, L.E. Arnold, B.J. Freeman, A. Martin, J.J. McGough, P. Cronin, D.J. Posey, M.A. Riddle, L. Ritz, N.B. Swiezy, B. Vitiello, F.R. Volkmar, N.A. Votolato, and P. Walson Research Units on Pediatric Psychopharmacology (RUPP) autism Network. Background and rationale for an initial controlled study of risperidone Child. Adolesc. Psychiatr. Clin. N. Am. 9 2000 201 224
52. H.G. McFarlane, G.K. Kusek, M. Yang, J.L. Phoenix, V.J. Bolivar, and J.N. Crawley Autism-like behavioral phenotypes in BTBR T+tf/J mice Genes Brain Behav. 7 2008 152 163
53. M.L. McPheeters, Z. Warren, N. Sathe, J.L. Bruzek, S. Krishnaswami, R.N. Jerome, and J. Veenstra-Vanderweele A systematic review of medical treatments for children with autism spectrum disorders Pediatrics May 127 5 2011 e1312-21
54. M.V. Mehta, M.J. Gandal, and S.J. Siegel mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism PLoS One 6 2011 e26077
55. L. Meikle, K. Pollizzi, A. Egnor, I. Kramvis, H. Lane, M. Sahin, and D.J. Kwiatkowski Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function J. Neurosci. 28 2008 5422 5432
56. B. Moisset, and B.L. Welch Effects of d-amphetamine upon open field behaviour in two inbred strains of mice Experientia 29 1973 625 626
57. M.C. Montana, L.F. Cavallone, K.K. Stubbert, A.D. Stefanescu, E.D. Kharasch, and R.W. Gereau 4th The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine J. Pharmacol. Exp. Ther. 330 2009 834 843
58. S.S. Moy, J.J. Nadler, N.B. Young, A. Perez, L.P. Holloway, R.P. Barbaro, J.R. Barbaro, L.M. Wilson, D.W. Threadgill, J.M. Lauder, T.R. Magnuson, and J.N. Crawley Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains Behav. Brain Res. 176 2007 4 20
59. S.S. Moy, J.J. Nadler, N.B. Young, R.J. Nonneman, S.K. Segall, G.M. Andrade, J.N. Crawley, and T.R. Magnuson Social approach and repetitive behavior in eleven inbred mouse strains Behav. Brain Res. 191 2008 118 129
60. K. Mueller, P.M. Kunko, D. Whiteside, and C. Haskett Time course of amphetamine-induced locomotor stereotypy in an open field Psychopharmacology (Berl) 99 1989 501 507
61. J.J. Nadler, S.S. Moy, G. Dold, D. Trang, N. Simmons, A. Perez, N.B. Young, R.P. Barbaro, J. Piven, T.R. Magnuson, and J.N. Crawley Automated apparatus for quantitation of social approach behaviors in mice Genes Brain Behav. 3 2004 303 314
62. Network, R. U. o. P. P. R. A Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity Arch. Gen. Psychiatry 62 2005 1266 1274
63. K. Nickels, S.K. Katusic, R.C. Colligan, A.L. Weaver, R.G. Voigt, and W.J. Barbaresi Stimulant medication treatment of target behaviors in children with autism: a population-based study J. Dev. Behav. Pediatr. 29 2008 75 81
64. S.M. Nicola, S.B. Kombian, and R.C. Malenka Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors J. Neurosci. 16 1996 1591 1604
65. R.E. Nordquist, S. Durkin, G. Jaeschke, and W. Spooren Stress-induced hyperthermia: effects of acute and repeated dosing of MPEP Eur. J. Pharmacol. 568 2007 199 202
66. M. Ogier, H. Wang, E. Hong, Q. Wang, M.E. Greenberg, and D.M. Katz Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome J. Neurosci. 27 2007 10912 10917
67. J.B. Panksepp, K.A. Jochman, J.U. Kim, J.J. Koy, E.D. Wilson, Q. Chen, C.R. Wilson, and G.P. Lahvis Affiliative behavior, ultrasonic communication and social reward are influenced by genetic variation in adolescent mice PLoS One 2 2007 e351
68. F. Papaleo, J.N. Crawley, J. Song, B.K. Lipska, J. Pickel, D.R. Weinberger, and J. Chen Genetic dissection of the role of catechol-O- methyltransferase in cognition and stress reactivity in mice J. Neurosci. 28 2008 8709 8723
69. F. Papaleo, J.L. Silverman, J. Aney, Q. Tian, C.L. Barkan, K.K. Chadman, and J.N. Crawley Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice Learn. Mem. 18 2011 534 544
70. B.L. Pearson, R.L. Pobbe, E.B. Defensor, L. Oasay, V.J. Bolivar, D.C. Blanchard, and R.J. Blanchard Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism Genes Brain Behav. 10 2011 228 235
71. O. Penagarikano, B.S. Abrahams, E.I. Herman, K.D. Winden, A. Gdalyahu, H. Dong, L.I. Sonnenblick, R. Gruver, J. Almajano, A. Bragin, P. Golshani, J.T. Trachtenberg, E. Peles, and D.H. Geschwind Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits Cell 147 2011 235 246
72. A. Pilc, A. Klodzinska, P. Branski, G. Nowak, A. Palucha, B. Szewczyk, E. Tatarczynska, E. Chojnacka-Wojcik, and J.M. Wieronska Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats Neuropharmacology 43 2002 181 187
73. R.L. Pobbe, B.L. Pearson, E.B. Defensor, V.J. Bolivar, D.C. Blanchard, and R.J. Blanchard Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system Behav. Brain Res. 214 2010 443 449
74. R.L. Pobbe, E.B. Defensor, B.L. Pearson, V.J. Bolivar, D.C. Blanchard, and R.J. Blanchard General and social anxiety in the BTBR T+tf/J mouse strain Behav. Brain Res. 216 2011 446 451
75. H. Quintana, B. Birmaher, D. Stedge, S. Lennon, J. Freed, J. Bridge, and L. Greenhill Use of methylphenidate in the treatment of children with autistic disorder J. Autism Dev. Disord. 25 1995 283 294
76. J.M. Rivet, L. Stinus, M. LeMoal, and P. Mormede Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation Brain Res. 498 1989 149 153
77. T. Robbins, and S.D. Iversen A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats Psychopharmacologia 28 1973 155 164
78. S.J. Rogers, and L.A. Vismara Evidence-based comprehensive treatments for early autism J. Clin. Child. Adolesc. Psychol. 37 2008 8 38
79. F.I. Roullet, M. Wohr, and J.N. Crawley Female urine-induced male mice ultrasonic vocalizations, but not scent-marking, is modulated by social experience Behav. Brain Res. 216 2011 19 28
80. B.C. Ryan, N.B. Young, J.N. Crawley, J.W. Bodfish, and S.S. Moy Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain Behav. Brain Res. 208 2010 178 188
81. M.L. Scattoni, S.U. Gandhy, L. Ricceri, and J.N. Crawley Unusual repertoire of vocalizations in the BTBR T+tf/J mouse model of autism PLoS One 3 2008 e3067
82. M.L. Scattoni, L. Ricceri, and J.N. Crawley Unusual repertoire of vocalizations in adult BTBR T+tf/J mice during three types of social encounters Genes Brain Behav. 10 2011 44 56
83. T.L. Sills, A.O. Onalaja, and J.N. Crawley Mesolimbic dopaminergic mechanisms underlying individual differences in sugar consumption and amphetamine hyperlocomotion in Wistar rats Eur. J. Neurosci. 10 1998 1895 1902
84. J.L. Silverman, S.S. Tolu, C.L. Barkan, and J.N. Crawley Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP Neuropsychopharmacology 35 2010 976 989
85. J.L. Silverman, M. Yang, C. Lord, and J.N. Crawley Behavioural phenotyping assays for mouse models of autism Nat. Rev. Neurosci. 11 2010 490 502
86. J.L. Silverman, M. Yang, S.M. Turner, A.M. Katz, D.B. Bell, J.I. Koenig, and J.N. Crawley Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism Neuroscience 171 2010 1197 1208
87. J.L. Silverman, S.M. Turner, C.L. Barkan, S.S. Tolu, R. Saxena, A.Y. Hung, M. Sheng, and J.N. Crawley Sociability and motor functions in Shank1 mutant mice Brain Res. 1380 2011 120 137
88. J.L. Silverman, D.G. Smith, S.J. Rizzo, M.N. Karras, S.M. Turner, S.S. Tolu, D.K. Bryce, D.L. Smith, K. Fonseca, R.H. Ring, and J.N. Crawley Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism Sci. Transl. Med. 4 131 Apr 25 2012 131ra51
89. W.P. Spooren, A. Vassout, H.C. Neijt, R. Kuhn, F. Gasparini, S. Roux, R.D. Porsolt, and C. Gentsch Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents J. Pharmacol. Exp. Ther. 295 2000 1267 1275
90. U. Stromberg, and T.H. Svensson Differences between (+)- and (-)-amphetamine in effects on locomotor activity and L-dopa potentiating action in mice Naunyn Schmiedebergs Arch. Pharmacol. 287 1975 171 179
91. K. Sullivan, D. Hatton, J. Hammer, J. Sideris, S. Hooper, P. Ornstein, and D. Bailey Jr. ADHD symptoms in children with FXS Am. J. Med. Genet. A 140 2006 2275 2288
92. E. Tatarczynska, A. Klodzinska, E. Chojnacka-Wojcik, A. Palucha, F. Gasparini, R. Kuhn, and A. Pilc Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist Br. J. Pharmacol. 132 2001 1423 1430
93. A.M. Thomas, N. Bui, J.R. Perkins, L.A. Yuva-Paylor, and R. Paylor Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome Psychopharmacology (Berl) 219 2012 47 58
94. J.W. Varni, B.L. Handen, P.K. Corey-Lisle, Z. Guo, G. Manos, D.K. Ammerman, R.N. Marcus, R. Owen, R.D. McQuade, W.H. Carson, S. Mathew, and R. Mankoski Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials Clin. Ther. 34 4 Apr 2012 980 992 Epub 2012 Mar 22
95. J. Veenstra-VanderWeele, and R.D. Blakely Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments Neuropsychopharmacology 37 2012 196 212
96. R. Ventura, T. Pascucci, M.V. Catania, S.A. Musumeci, and S. Puglisi-Allegra Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex Behav. Pharmacol. 15 2004 433 442
97. S. Williams White, K. Keonig, and L. Scahill Social skills development in children with autism spectrum disorders: a review of the intervention research J. Autism Dev. Disord. 37 2007 1858 1868
98. L.K. Wink, C.A. Erickson, and C.J. McDougle Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders Curr. Treat. Options Neurol. 12 2010 529 538
99. M. Wohr, F.I. Roullet, and J.N. Crawley Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of autism Genes Brain Behav. 10 2011 35 43
100. Q.J. Yan, M. Rammal, M. Tranfaglia, and R.P. Bauchwitz Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP Neuropharmacology 49 2005 1053 1066
101. M. Yang, M.L. Scattoni, V. Zhodzishsky, T. Chen, H. Caldwell, W.S. Young, H.G. McFarlane, and J.N. Crawley Social approach behaviors are similar on conventional versus reverse lighting cycles, and in replications across cohorts, in BTBR T+ tf/J, C57BL/6J, and vasopressin receptor 1B mutant mice Front. Behav. Neurosci. 1 2007 1
102. M. Yang, V. Zhodzishsky, and J.N. Crawley Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers Int. J. Dev. Neurosci. 25 2007 515 521
103. M. Yang, A.M. Clarke, and J.N. Crawley Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability Eur. J. Neurosci. 29 2009 1663 1677
104. M. Yang, K. Perry, M.D. Weber, A.M. Katz, and J.N. Crawley Social peers rescue autism-relevant sociability deficits in adolescent mice Autism Res. 4 2011 17 27
105. M. Yang, J.L. Silverman, and J.N. Crawley Automated three-chambered social approach task for mice Curr. Protoc. Neurosci. 2011 (Chapter 8), Unit 8 26
106. M. Yang, D.N. Abrams, J.Y. Zhang, M.D. Weber, A.M. Katz, A.M. Clarke, J.L. Silverman, and J.N. Crawley Low sociability in BTBR T+tf/J mice is independent of partner strain Physiol. Behav. 2012
107. M. Yang, O. Bozdagi, M.L. Scattoni, M. Wöhr, F.I. Roullet, A.M. Katz, D.N. Abrams, D. Kalikhman, H. Simon, J.Y. Zhang, M.J. Harris, R. Saxena, J.L. Silverman, J.D. Buxbaum, and J.N. Crawley Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent shank3 null mutant mice J. Neurosci. 32 19 2012 6525 6541
108. J.W. Yates, J.T. Meij, J.R. Sullivan, N.M. Richtand, and L. Yu Bimodal effect of amphetamine on motor behaviors in C57BL/6 mice Neurosci. Lett. 427 2007 66 70
109. J. Zhou, J. Blundell, S. Ogawa, C.H. Kwon, W. Zhang, C. Sinton, C.M. Powell, and L.F. Parada Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice J. Neurosci. 29 2009 1773 1783
110. L. Zwaigenbaum, S. Bryson, C. Lord, S. Rogers, A. Carter, L. Carver, K. Chawarska, J. Constantino, G. Dawson, K. Dobkins, D. Fein, J. Iverson, A. Klin, R. Landa, D. Messinger, S. Ozonoff, M. Sigman, W. Stone, H. Tager-Flusberg, and N. Yirmiya Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants Pediatrics 123 2009 1383 1391